Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Mazda to build Module Pack Plant for Cylindrical Lithium-ion Batteries for Automotive Use in Iwakuni City, Yamaguchi Prefecture
-
Cainiao deploys latest L4 autonomous delivery vehicle for public roads
-
STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against Capri Holdings Limited (CPRI)
-
DIONE Protocol Debuts on XT.COM: AI-Driven and 100% Renewable
-
Secure and Private: PIVX Futures Debut on XT.COM
-
WhistlinDiesel Launches 2nd Cybertruck vs. F-150 Durability Test Video
-
Tianma showcasing wide range of new display products and prototype technologies at CES 2025
-
Hyundai Motor Group Executive Chair Euisun Chung Outlines 2025 Vision Driven by Commitment to Innovation, Overcoming Challenges, and Creating Opportunities in New Year's Message
-
STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against Marqeta, Inc. (MQ)
-
Ecora Resources PLC Announces 2024 Interim Dividend: Amounts per Ordinary Share
-
Guardian Metal Resources PLC Announces £750,000 Placing with Institutional Investor
-
Genflow Biosciences PLC Announces 2024 Highlights
-
Arrow Announces Exploration Well AB-1 Results
-
Orosur Mining Inc Announces Exercise of Warrants
-
European Commission (EC) Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)
-
L'Oréal Groupe Unveils L'Oréal Cell BioPrint, a Revolution in Consumer Skin Intelligence Rooted in the Field of Longevity Science, at CES 2025
-
Acticor Biotech announces its liquidation proceedings
-
PureTech Appoints UBS as UK Corporate Broker
-
BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe
-
Pulsar Helium Announces Drilling Has Commenced at the Jetstream #1 Appraisal Well, Topaz Project, Minnesota, USA
-
HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 9)
-
Aktsiaselts Infortar exits from the taxi service business sector
-
Transaction in own shares
-
Nidec Announces the Status of Own Share Repurchase
-
TomTom and Esri partner to deliver advanced location analytics
-
Azerion Announces Leadership Team Members' Share Purchases
-
Toyoda Gosei to Exhibit in the Uno Minda Group Booth at Bharat Mobility Global Expo 2025 in India
-
Riema Labs Inc. (Nubit) Unveils Goldinals: The Unified Protocol for Bitcoin Assets
-
Colle AI (COLLE) App Goes Live on iOS, Delivering Multichain AI and Web3 Capabilities
-
Colle AI (COLLE) App Goes Live on iOS, Delivering Multichain AI and Web3 Capabilities
-
Colle AI (COLLE) App Goes Live on iOS, Delivering Multichain AI and Web3 Capabilities
-
Colle AI (COLLE) App Goes Live on iOS, Delivering Multichain AI and Web3 Capabilities
-
Colle AI (COLLE) App Goes Live on iOS, Delivering Multichain AI and Web3 Capabilities
-
Colle AI (COLLE) App Goes Live on iOS, Delivering Multichain AI and Web3 Capabilities
-
Colle AI (COLLE) App Goes Live on iOS, Delivering Multichain AI and Web3 Capabilities
-
Saint O, Afro-Caribbean Jazz Sensation, Unveils New Album One Life To Live and New Website on the Not Just Jazz Network
-
Geely Auto sales exceeded 2.17 million units, international market growth exceeds 53%
-
Press release: Sequana Medical Announces Key Opinion Leader (KOL) Webinar to Discuss alfapump® US Commercial Roll-Out on January 8th at 15:00 CET / 09:00 EST
-
Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group
-
AI Connect to Launch Revolutionary AI Agent, Redefining Financial and Technological Innovation
-
Start of Day Message
-
Press release: Sequana Medical Announces Key Opinion Leader (KOL) Webinar to Discuss alfapump® US Commercial Roll-Out on January 8th at 15:00 CET / 09:00 EST
-
NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease
-
Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group
-
Update on pre-acceptances for the recommended voluntary cash offer of NOK 20.50 per share to the shareholders of Belships ASA
-
TGS Announces Dawson III 3D Seismic Survey in the Western Canadian Sedimentary Basin
-
argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Battison Honda Welcomes the 2025 Honda Odyssey to its Inventory
-
Acbel Unveils New Logo, Signaling a Value-Driven Future

